Vista Pharmaceuticals Share Price

Vista Pharmaceuticals

CMP as on25-Jan-21 15:26

₹ 10.50
0.2 1.94%

Open

₹ 10.30

Turnover (lac)

₹ 2

Prev. Close

₹ 10.30

Day's Vol (shares)

₹ 2,837

Day's Range

₹ 10.20
₹ 10.81

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 05-Nov-2020 - -
VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2020 ,inter alia, to consider and approve With reference to the subject cited, the meeting of the Board of Directors of the Company M/s. Vista Pharmaceuticals Limited will be held on Thursday, 12.11.2020 at 4.30 P.M at the Corporate office of the Company Situated at 7-1-212/A/70, 1st Floor, Plot No. 85, Shivbagh, Ameerpet, Hyderabad- 500016, Telangana inter-alai to discuss the following: 1. To consider, approve and take on record the un-audited Financial Results of the company for the quarter and half year ended 30th September, 2020. 2. To consider and take note of Limited Review Report for the quarter and half year ended 30th September, 2020. 3. Any other items with permission of chairman. This is for the kind information and records of the Exchange. With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its Meeting held on Thursday, 12th September, 2020 at 4:30 PM, at the corporate office of the Company inter-alia considered and approved the following: 1. Un-Audited Financial Results for the quarter and half year ended 30th September, 2020. 2. Limited Review Report for the quarter and half year ended 30th September, 2020. 3. Draft Board of Directors Report on the companys activities for the financial year ended March 31st, 2020. 4. To convene the 29th Annual General Meeting of the company for the financial year 2019-2020 to be held on Saturday, 19th December, 2020. 5. Draft Notice for the 29th Annual General Meeting of the Members of the Company. 6. Draft Secretarial Audit Report for the financial year ended 31st March, 2020. Other items as per signed outcome. (As Per Bse Announcement Dated on 12/11/2020)
Board Meeting - 07-Sep-2020 - -
Quarterly Results VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/09/2020 ,inter alia, to consider and approve With reference to the subject cited, the meeting of the Board of Directors of the Company M/s. Vista Pharmaceuticals Limited will be held on Monday, 14.09.2020 at 04.00 P.M at the Corporate office of the Company Situated at 7-1-212/A/70, 1st Floor, Plot No. 85, Shivbagh, Ameerpet, Hyderabad- 500016, Telangana inter-alai to discuss the following: 1. To consider, approve and take on record the un-audited Financial Results of the company for the quarter ended 30th June, 2020. 2. To consider and take note of Limited Review Report for the quarter ended 30th June, 2020. This is for the kind information and records of the Exchange. (AS Per BSE Announcement Dated on 07.09.2020)
Board Meeting - 18-Aug-2020 - -
Dear Sir/Maam, With reference to the subject cited, this is to inform the Exchange that at the meeting of the Board of Directors of M/s. Vista Pharmaceuticals Limited held today, i.e., 18th August, 2020 at 4.30 P.M. at the corporate office of the company situated at 7-1-212/A/70, 1st Floor, Plot No. 85, Shivbagh, Ameerpet, Hyderabad- 500016, Telangana, has considered the following: 1. Accepted the resignation of Mr. Arjun Upadhyay, as Company Secretary, Compliance officer and Key Managerial Personnel of the Company with immediate effect.
Board Meeting - 13-Jul-2020 - -
With reference to the subject cited, this is to inform the Exchange that at the meeting of the Board of Directors of M/s. Vista Pharmaceuticals Limited held today, i.e., 13th July, 2020 at 3.00 P.M. at the corporate office of the company situated at 7-1-212/A/70, 1st Floor, Plot No. 85, Shivbagh, Ameerpet, Hyderabad- 500016, Telangana, the Board considered and approved the following: 1. Allotment of 10,71,428 equity shares to Mr. Umakanth Katta, the Non promoter of the Company at an issue price of Rs. 14/- per share (Rupees Fourteen only) (Including a premium of Rs. 12/- per share) aggregating to Rs. 1.50/- Crore (Rupees One Crore and Fifty Lakhs Only). 2. Appointment of Mr. Umakanth Katta (DIN: 07438554) as Non- Executive Non Independent Additional Director on the Board of the Company with Immediate effect. This is for the kind information and records of the Exchange. Quarterly Results (Revised) & (Revised) & Audited Results (As per BSE Bulletin Dated on 21/07/2020) VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2020 ,inter alia, to consider and approve With reference to the subject cited, the meeting of the Board of Directors of Vista Pharmaceuticals Limited scheduled to be held today on Monday, July 20th, 2020 at 4.30 P.M at the corporate office of the company at 7-1-212/A/70, 1st Floor, Plot No. 85, Shivbagh, Ameerpet, Hyderabad- 500 016, Telangana, have been postponed and the Managing Director in consultation with other Directors of the company has re-schedule the same meeting on Wednesday July 29th, 2020 at 4.30 P.M at the corporate office of the company, inter-alia to discuss the following: 1. To consider, approve and take on record the audited Financial Results of the company for the quarter and year ended 31stMarch, 2020. 2. To consider and take note of draft Auditors Report for the quarter and year ended 31stMarch, 2020. 3. To appoint Secretarial Auditor for the financial year 2019-2020 and Internal Auditors for the financial year 2020-21 of the Company. (As per BSE Announcement Dated on 20/07/2020) With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its Meeting held on Wednesday, 29th July, 2020 at 04:30 PM, at the corporate office of the Company to inter-alia considered and approved the following: 1. Audited financial statements of the Company for the quarter and financial year ended 31st March, 2020. 2. Draft Auditors Report on the financial statements of the Company for the financial year ended 31st March, 2020. 3. Appointment of a) M/s. V. Durga Prasad & Associates, Chartered Accountants as Internal Auditors of the Company for the FY 2020-21. b) Mr. NVSS Suryanarayana Rao, Practicing Company Secretary, as Secretarial Auditor of the Company for the FY 2019-2020. Kindly take the same on record and acknowledge the receipt of the same. With reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its meeting held on Wednesday, 29th July, 2020 at 04.30 P.M. at the Corporate office of the Company, interalia, considered and approved the audited Financial Results for the quarter and year ended 31st March, 2020. Copy of audited Financial Results for the quarter and year ended 31st March, 2020, along with Statement of Assets and Liabilities and Audit Report is enclosed herewith. Kindly take the same on record and acknowledge the receipt of the same. (AS Per BSE Announcement Dated on 29.07.2020)
Board Meeting - 12-Jul-2020 - -
VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/07/2020 ,inter alia, to consider and approve With reference to the subject cited, the meeting of the Board of Directors of the Company M/s. Vista Pharmaceuticals Limited will be held on Monday, 20.07.2020 at 4.30 P.M at the Corporate office of the Company Situated at 7-1-212/A/70, 1st Floor, Plot No. 85, Shivbagh, Ameerpet, Hyderabad- 500016, inter-alai to discuss the following: 1. To consider, approve and take on record the audited Financial Results of the company for the quarter and year ended 31stMarch, 2020. 2. To consider and take note of draft Auditors Report for the quarter and year ended 31stMarch, 2020. 3. To appoint Secretarial Auditor for the financial year 2019-2020 and Internal Auditors for the financial year 2020-21 of the Company. 4. Other matter with permission of chairman. This is for the kind information and records of the Exchange.
Board Meeting - 07-Jul-2020 - -
Dear Sir/Maam, With reference to the subject cited, this is to inform the Exchange that at the meeting of the Board of Directors of M/s. Vista Pharmaceuticals Limited held today, i.e., 07th July, 2020 at 4.00 P.M. at the corporate office of the company situated at 7-1-212/A/70, 1st Floor, Plot No. 85, Shivbagh, Ameerpet, Hyderabad- 500016, Telangana, the Board considered and approved the allotment of 10,71,428 equity shares to Mr. Umakanth Katta, the Non promoter of the Company at an issue price of Rs. 14/- per share (Rupees Fourteen only) (Including a premium of Rs. 12/- per share) aggregating to Rs. 1.50/- Crore (Rupees One Crore and Fifty Lakhs Only). This is for the kind information and records of the Exchange.
Board Meeting - 22-Jun-2020 - -
VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2020 ,inter alia, to consider and approve With reference to the subject cited, the meeting of the Board of Directors of the Company M/s. Vista Pharmaceuticals Limited will be held on Tuesday, 30.06.2020 at 04.30 P.M at the Corporate office of the Company Situated at 7-1-212/A/70, 1st Floor, Plot No. 85, Shivbagh, Ameerpet, Hyderabad- 500016, inter-alai to discuss the following: 1. To consider, approve and take on record the audited Financial Results of the company for the quarter and year ended 31st March, 2020. 2. To consider and take note of draft Auditors Report for the quarter and year ended 31st March, 2020. 3. To Appoint Secretarial Auditors for the financial year 2019-20. 4. To Appoint Internal Auditors for the financial year 2020-21. This is for the kind information and records of the Exchange. Vista Pharmaceuticals Ltd. 30/06/2020 Audited Results(Cancelled) (As Per BSE Bulletin Dated on 25-06-2020)
Board Meeting - 15-May-2020 - -
VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2020 ,inter alia, to consider and approve With reference to the subject cited, the meeting of the Board of Directors of the Company M/s. Vista Pharmaceuticals Limited will be held on Monday, 25th day of May, 2020 at 04.30 P.M at the Corporate office of the Company Situated at 7-1-212/A/70, 1st Floor, Plot No. 85, Shivbagh, Ameerpet, Hyderabad- 500016, Telangana inter-alai to consider and discuss the following: 1. Proposal to raise funds by way of issue of equity shares on preferential basis. 2. Any other business with the permission of chairman. This is for the kind information and records of the Exchange. In furtherance to our intimation letter dated May 15th, 2020 and with reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its Meeting held today i.e., Monday, 25th May, 2020 at 4:30 PM, at the corporate office of the Company has considered and approved for issue of 78,57,142 equity shares on preferential basis to other (public). This is for the kind information and records of the Exchange. (As Per BSE Announcement Dated on 25.05.2020) In furtherance to our intimation letter dated May 15th, 2020 and with reference to the subject cited, it is hereby informed that the Board of Directors of the Company at its Meeting held on Monday, 25th May, 2020 at 4:30 PM, at the corporate office of the Company has considered and approved issue of 78,57,142 equity shares on preferential basis to promoter and others. (As Per BSE Announcement dated on 26.05.2020)
Board Meeting - 04-Feb-2020 - -
VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2020 ,inter alia, to consider and approve With reference to the subject cited, the meeting of the Board of Directors of the Company M/s. Vista Pharmaceuticals Limited will be held on Thursday, 13th day of February, 2020 at 04.00 P.M at the Corporate office of the Company Situated at 7-1-212/A/70, 1st Floor, Plot No. 85, Shivbagh, Ameerpet, Hyderabad- 500016, Telangana inter-alai to discuss the following: 1.To consider, approve and take on record the un-audited Financial Results of the company for the quarter ended 31st December, 2019. 2.To consider and take note of Limited Review Report for the quarter ended 31st December, 2019. 3.To take note and accept resignation of Mr. Venkata Chalapathi Rao Naraparaju (DIN: 03270178) Whole time Director of the Company. 4.Any other items with the permission of chairman. This is for the kind information and records of the Exchange. Outcome of the Board Meeting Financial Results for the quarter ended 31st December, 2019-Regulation 33(3)(a). (As Per BSE Announcement dated on 13/02/2020)